Inovio Pharmaceuticals, Inc. (INO)
2.27
+0.12
(+5.58%)
USD |
NASDAQ |
Dec 24, 12:59
2.27
0.00 (0.00%)
After-Hours: 13:59
Inovio Pharmaceuticals SG&A Expense (TTM): 33.07M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Agenus, Inc. | 63.03M |
| Perspective Therapeutics, Inc. | 31.53M |
| Arcturus Therapeutics Holdings, Inc. | 44.43M |
| Capricor Therapeutics, Inc. | 21.94M |
| Myomo, Inc. | 32.71M |